Atlas Trials

Post Marketing Surveillance of Nintedanib in Indian Patients With Idiopathic Pulmonary Fibrosis

Clinical trial NCT03047031 · COMPLETED

Trial details

NCT number
NCT03047031
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Study type
OBSERVATIONAL
Idiopathic Pulmonary Fibrosis
Start date
2017-04-05
Primary completion
2022-07-21
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.